Elsevier

Brain Research

Volume 800, Issue 2, 3 August 1998, Pages 227-235
Brain Research

Research report
Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress

https://doi.org/10.1016/S0006-8993(98)00515-0Get rights and content

Abstract

In the present study, we examined the effect of metyrapone, an inhibitor of corticosterone (CS) synthesis, on the behavioral and neurochemical sequelae induced by a brief restraint session. A 15-min stress period induced an anxiogenic-like behavior on the elevated plus-maze (EPM), which was reversed with metyrapone (75 mg/kg i.p.) injected 3 h prior to the stress event. It was further demonstrated that metyrapone pretreatment normalized the decrease in maximal chloride uptake following GABA stimulation observed in brain cortex tissue obtained from animals exposed to both restraint and the EPM. In addition, plasma CS levels were assessed both after restraint and following EPM exposure. Furthermore, the administration of both CS (2.5 mg/kg s.c. at a dose that mimics CS levels induced by restraint) or dexamethasone (DEXA, 1.25 μg/kg s.c) resulted in an anxiogenic response in the EPM comparable to that induced by restraint. Taken together, all these evidence suggest that CS released in response to stress seems to be associated with functional changes at the GABAergic supramolecular complex which could underlie the enhanced anxiety observed following the exposure to an aversive experience.

Introduction

Evidence from clinical studies suggests a good correlation between the degree of anxiety in humans and plasma concentrations of cortisol 4, 46. Increases in circulating cortisol, whether endogenously produced by stress, pathological states such as Cushing's disease, depression or other psychiatric disorders, or, as effected through exogenous administration, are often associated with a state of anxiety characterized by a sense of apprehension and fear 14, 25, 53.

Circulating corticosteroids enter the brain, where they bind to intracellular mineralocorticoid and glucocorticoid receptors (MR and GR). The MR and GR are both localized in high densities in certain brain structures involved in emotional behavior such as septum, amygdala, hippocampus and cerebral cortex 9, 24, 52. Adrenal glucocorticoids appear to have a dual and frequently opposite action on the behavioral expression of fear and anxiety. For instance, some report that corticosterone (CS) administration may cause anxiolytic-like effects, whereas adrenalectomy may produce anxiogenic-like effects, which can be reversed by CS replacement therapy 13, 54. In contrast, fear-motivated immobility can be abolished by adrenalectomy and restored after CS administration [6]. Moreover, recent reports have shown either anxiolytic or anxiogenic-like effects following treatment with MR and/or GR antagonists in various animal models of anxiety, meanwhile, a recent review argues for an anxiolytic effect of the hormone 22, 23, 41.

The mechanism(s) by which CS regulates the expression of anxiety is not yet known. The GABAergic system may be one potential mediator of this modulation since CS affects the activity of GABAergic neurons. Additionally, it is well-established that GABA is critically involved in the effect of anxiolytic drugs and, consequently, in anxiety response [5]. Indeed, glucocorticoids have been shown to modulate the density of GABA 27, 28, TBPS [29]and benzodiazepine binding sites [28], as well as GABA-mediated chloride flux in vitro [38]. In addition, adrenalectomy-induced changes in [3H] GABA [21], [3H] muscimol [27], and [3H] flunitrazepan [11]binding in selective brain regions have been reported. Furthermore, adrenalectomy reverses the effect of acute stress on GABA activated chloride influx and modifies the alteration of benzodiazepine binding sites induced by prior stress 34, 47, 55, 56.

Taken together, all these results suggest a possible involvement of adrenal steroids in the modulation of, at least some, behavioral and neurochemical changes associated with the exposure to an aversive event.

In accordance with previous reports [1], we have recently demonstrated that a previous exposure to a brief restraint session induced an anxiogenic-like behavior assessed in the elevated plus-maze (EPM), where fear is behaviorally expressed by rats' passive avoidance of novel open arms 17, 39, 44. This behavioral response was paralleled by a clear reduction of cortical chloride uptake following GABA stimulation [31]. Considering that exposure to such a brief restraint induced a robust increase in CS secretion [31], the present study was conducted to examine the potential involvement of CS in the behavioral sequelae and in the functional changes of the GABAA receptor complex induced by this brief aversive experience (15-min restraint session).

Accordingly, we addressed the following issues: (a) the effect(s) of metyrapone, a 11-β-hydroxylase inhibitor that blocks CS synthesis, administered before restraint, on the subsequent behavioral performance in the EPM and on the activity of the supramolecular GABAA complex, in pooled cortical tissue in vitro by means of chloride uptake assessment following GABA stimulation; (b) the effect of metyrapone on the time course of changes in serum CS concentrations, determined in individual rats, before and after exposure to the restraint session and also before and after the subsequent exposure to the EPM; (c) whether exogenous corticosteroid administration, either CS or the synthetic corticosteroid dexamethasone (DEXA), could mimic the behavioral alteration in the EPM observed following the exposure to the restraint session.

Section snippets

Animals

Male Wistar rats from our breeding stock, weighing 280–320 g were used. Animals were housed in groups of 6 per cage with a constant light–dark cycle (lights off from 1900 to 0700 h). Temperature (22°C) and humidity (60%) were also kept constant. Animals were allowed at least 1 week of habituation to the animal room. Experiments were performed between 1100 and 1400 h, with the experimenter unaware of the treatment condition.

Restraint

Rats were transferred to an experimental room where the stressor was

Experiment 1

This experiment was devised to evaluate the effect of metyrapone on behavioral performance in the EPM in animals with or without the previous restraint experience. Rats were handled daily for 1 week prior to testing, namely, removed, weighed, and returned to their home cages. On day eight, subjects were randomly divided into four groups. The four groups comprised a 2×2 factorial design. Rats were given either metyrapone (n=15) or vehicle (n=14) 3 h before restraint; a similar treatment was

Experiment 1: effect of metyrapone on the behavioral responses to restraint

As was described in a previous report [31], the exposure to a 15 min restraint session induced a decrease in the percentage of time spent on open arms (treatment F1,50=8.62, p<0.005) as compared with unrestrained animals.

Metyrapone treatment significantly modified the decrease in the percentage of time spent on open arms induced by restraint (treatment×stress interaction, F1,50=5.89, p<0.019) (Fig. 1). Metyrapone- and vehicle-unrestrained animals did not significantly differ in percentage of

Discussion

As previously reported [31], the exposure to as little as 15 min of restraint resulted in significant behavioral and neurochemical changes when stressed animals were subsequently tested in the EPM 24 h later. These changes were manifested as a reduced open arm activity, and a decreased efficacy and potency of GABA to stimulate Cl flux in cerebral cortical membranes.

The present study shows that the behavioral consequences induced by a brief restraint, and the associated changes in GABAA

Acknowledgements

This research was supported by grants from CONICOR, SECYT-UNC and CONICET (Argentina). The authors are grateful to Elsa Pereyra and Estela Salde for their technical assistance and to Cristina Aráoz for generously providing us with horse serum.

References (57)

  • S.M Korte et al.

    Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety

    Pharmacol. Biochem. Behav.

    (1996)
  • M.D Majewska et al.

    Glucocorticoids are modulators of GABAA receptors in brain

    Brain Res.

    (1985)
  • M.D Majewska

    Antagonist-type interaction of glucocorticoids with the GABA receptor-coupled chloride channel

    Brain Res.

    (1987)
  • I.D Martijena et al.

    Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates

    Brain Res.

    (1997)
  • B.S McEwen

    Non-genomic and genomic effects of steroids on neural activity

    Trends Pharmacol. Sci.

    (1991)
  • L.G Miller et al.

    Modulation of benzodiazepine receptors in rat brain are alterated by adrenalectomy and steroid replacement

    Brain Res.

    (1988)
  • S Pellow et al.

    Validation of open:closed arms in an elevated plus-maze as a measure of anxiety in the rat

    J. Neurosci. Methods

    (1985)
  • P.V Piazza et al.

    Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications

    Brain Res. Rev.

    (1997)
  • E.J Sachar

    Psychological factors relating to activation and inhibition of the adrenocortical response in man: a review

    Prog. Brain Res.

    (1970)
  • R.D Schwartz et al.

    Acute stress enhances the activity of GABA receptor-gated chloride ion channel in brain

    Brain Res.

    (1987)
  • J.W Smythe et al.

    Muscarinic antagonists are anxiogenic in rats tested in the black–white box

    Pharmacol. Biochem. Behav.

    (1996)
  • R.L Spencer et al.

    Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid

    Brain Res.

    (1990)
  • A.B Steffens

    A method from frequent sampling blood and continuous infusion of fluids in the rat without disturbing the animal

    Physiol. Behav.

    (1969)
  • A Weizman et al.

    Adrenalectomy prevents the stress-induced decrease in in vivo [3H]Ro15-1788 binding to GABAA benzodiazepine receptors in the mouse

    Brain Res.

    (1990)
  • R.M Zacharko et al.

    Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization

    Prog. Neurobiol.

    (1995)
  • M.E Albonetti et al.

    Behavioral responses to single and repeated restraint in male and female rats

    Behav. Processes

    (1992)
  • M.C Bennett et al.

    Serum corticosterone levels predicts the magnitude of hippocampal primed burst potentiation and depression in urethane-anesthetized rats

    Psychobiology

    (1991)
  • F.M Berger

    Effect of antianxiety drugs on fear and stress

    Behav. Sci.

    (1980)
  • Cited by (0)

    View full text